Prot# PR104-2002: A Randomized Phase I/II, Multi-Center, Open-Label Trial of PR104 and Sorafenib in Patients with Advanced Hepatocellular Carcinoma

Project: Research project

Project Details

StatusFinished
Effective start/end date2/18/09 → 2/18/12

Funding

  • Proacta, Inc. (PR104-2002)